An agarose spot chemotaxis assay for chemokine receptor antagonists

Journal of Pharmacological and Toxicological Methods

Volumn 64, Issue 3, 2011, Pages 213-216

  Vinader, Victoria ^a   Al Saraireh, Yousef ^a   Wiggins, Helen L ^b   Rappoport, Joshua Z ^b   Shnyder, Steve D ^a   Patterson, Laurence H ^a   Afarinkia, Kamyar ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

AMD3100; Antagonist; Assay; Chemotaxis; CXCR4; ICT5040

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; ICT 5040; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

AGAROSE SPOT CHEMOTAXIS ASSAY; ARTICLE; CELL ADHESION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; CHEMOTAXIS; FEMALE; HUMANS; IMMUNOLOGIC TECHNIQUES; RECEPTORS, CHEMOKINE; SEPHAROSE;

EID: 81955161277     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2011.01.004     Document Type: Article

References (22)

1. Abbott D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1a plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
2. Balkwill F. Chemokine biology in cancer. Seminars in Immunology 2003, 15:49-55.
3. Balkwill F. Cancer and the chemokine network. Nature Reviews. Cancer 2004, 4:540-550.
4. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Seminars in Cancer Biology 2004, 14:171-179.
5. Belmadani A., Tran P.B., Ren D., Assimacopoulos S., Grove E.A., Miller R.J. The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors. The Journal of Neuroscience 2005, 25:3995-4003.
6. Burger J.A., Kipps T.J. CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
7. De Clercq E. The bicyclam AMD3100 story. Nature Reviews. Drug Discovery 2003, 2:581-587.
8. De Clercq E. Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. Mini Reviews in Medicinal Chemistry 2005, 5:805-824.
9. Fricker S.P., Anastassov V., Cox J., Darkes M.C., Grujic O., Idzan S.R., et al. Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochemical Pharmacology 2006, 72:588-596.
10. Hatse S., Princen K., Bridger G., De Clercq E., Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Letters 2002, 527:255-262.
11. Li J.-K., Yu L., Shen Y., Zhou L.-S., Wang Y.-C., Zhang J.-H. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World Journal of Gastroenterology 2008, 14:2308-2313.
12. Luker K.E., Luker G.D. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Letters 2006, 238:30-41.
13. Matthys P., Hatse S., Vermeire K., Wuyts A., Bridger G., Henson G.W., et al. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-γ receptor-deficient mice. Journal of Immunology 2001, 167:4686-4692.
14. Nelson R.D., Quie P.G., Simmons R.L. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. Journal of Immunology 1975, 115:1650-1656.
15. Puglianiello A., Germani D., Rossi P., Cianfarani S. IGF-I stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin system. The Journal of Endocrinology 2000, 165:123-131.
16. Rehman A.O., Wang C.-U. SDF-1α promotes invasion of head and neck squamous cell carcinoma by activating NF-κB. The Journal of Biological Chemistry 2008, 283:19888-19894.
17. Tran P.B., Ren D., Veldhouse T.J., Miller R.J. Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. Journal of Neuroscience Research 2004, 76:20-34.
18. Varani J., Orr W., Ward P.A. A comparison of the migration patterns of normal and malignant cells in two assay systems. The American Journal of Pathology 1978, 90:159-172.
19. Vicari A.P., Caux C. Chemokines in cancer. Cytokine & Growth Factor Reviews 2002, 13:143-154.
20. Wiggins H.L., Rappoport J.Z. An agarose spot assay for chemotactic invasion. Biotechniques 2010, 48:121-124.
21. Yu H.S., Alam M. An agarose-in-plug bridge method to study chemotaxis in the Archaeon Halobacterium salinarum. FEMS Microbiology Letters 1997, 156:265-269.
22. Zlotnik A. Chemokines and cancer. International Journal of Cancer 2006, 119:2026-2029.